Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer |

« FDA Approvals - ARCA Discovery, Inc. Names Dr. Ann Lenich Hards Executive Vice | Main | FDA Approvals - Genentech Announces Second Quarter 2006 Results (FinanzNachrichten) SOUTH SAN FRANCISCO, »

Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer

Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer (PrimeZone via Yahoo! Finance)
Manhattan Pharmaceuticals, Inc. today announced that Michael G. McGuinness joined the company as Chief Financial Officer, effective today. Mr. McGuinness will have responsibility for accounting and reporting, strategic planning and analysis, treasury, tax, audit and Sarbanes-Oxley compliance.

Additional information in: FDA Recalls

FDA News Search

Get Legal Help

Breaking FDA Recalls

Breaking FDA Approvals

Health Tip

It’s a little known fact that coffee benefits your health in a variety of important ways .

Food & Drug Categories

FDA News Archive

Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources